FDA Coronavirus Disease 2019 (COVID-19) Update

Coronavirus Disease 2019 (COVID-19) Update

FDA is an active partner in the coronavirus disease (COVID-19) response, working closely with our government and public health partners across the U.S. Department of Health and Human Services, and with our international counterparts. Actions by the FDA in our ongoing response to the COVID-19 pandemic since our last email update include:

Coronavirus (COVID-19) Updates:

• May 12, 2020: Daily Roundup: FDA actions on treatment acceleration, inspection updates, and more
• May 11, 2020: FDA Takes New Actions to Accelerate Development of Novel Prevention, Treatment Options for COVID-19
• May 11, 2020: FDA updates on surveillance inspections during COVID-19
• May 9, 2020: FDA Authorizes First Antigen Test to Help in the Rapid Detection of the Virus that Causes COVID-19 in Patients
• May 8, 2020: FDA Authorizes First Diagnostic Test Using At-Home Collection of Saliva Specimens
• May 7, 2020: FDA Continues to Combat Fraudulent COVID-19 Medical Products

COVID-19 Bilingual Social Media Toolkit The FDA Office of Minority Health and Health Equity has published a bilingual social media toolkit, with graphics and information in English and Spanish. (The popular video pictured above, 12 Tips for Grocery Shopping During the Pandemic, is also available in Spanish.) You can access the toolkit on our website. Find additional coronavirus disease 2019 (COVID-19) updates on our website and in the Medical Countermeasures Initiative newsletter.